Free energy properties in cultured neural networks. by Takuya Isomura (839119)

“…<b>(D)</b> The change in 〈<i>U</i>〉, <i>H</i>, and <i>F</i> (trial 1 vs. trial 100). After training, the expectation of internal energy decreased (*, <i>p</i> = 0.023; <i>n</i> = 23 cultures), Shannon entropy significantly increased (****, <i>p</i> < 10⁻⁴; <i>n</i> = 23 cultures), and free energy significantly decreased (****, <i>p</i> < 10⁻⁴; <i>n</i> = 23 cultures). …”

Effects of intragastric infusion of Olanzapine (t = 130 to t = 290; 3 mg/kg/h) on glucose disappearance (Experiment 3). by Elodie M. Girault (144494)

“…<p>(Vehicle group n = 8, Olanzapine group n = 7) 5a: Endogenous glucose production at basal (mean of 3 time points: t = 90 to t = 100; white bars) and during the hyperinsulinemic state (mean of 5 time points: t = 250 to t = 290; black bars). …”

DataSheet_1_Effects of the neurotoxin β-N-methylamino-L-alanine (BMAA) on the early embryonic development of marine shellfish and fish.docx by Yilei Fu (14287574)

“…A sustained and dose-dependent decrease in heart rate was apparent in marine medaka embryos at 9-days post fertilization following BMAA exposure. …”

Chemical inhibition of Igf signaling suppresses cardiomyocyte proliferation during zebrafish heart regeneration. by Ying Huang (53474)

“…(C) Quantification of BrdU positive cardiomyocytes (Mef2 positive) ± S.E. A significant decrease (*<i>p</i><0.01) in cardiomyocyte proliferation was detected in fish treated with Igf1r inhibitor NVP-AEW541.…”

DataSheet1_Physiological evaluation of PVP-coated AgNP in the rat small intestine: an ex vivo approach.pdf by Jorge Antonio Chávez-Hernández (18854947)

“…Intestinal segments (duodenum, jejunum, and ileum) were treated in the presence and absence of five cumulative, increasing concentrations of AgNP (0.01, 0.1, 1, 10, and 100 μg/mL) and three individual concentrations of PVP-coated AgNP (0.01, 1, and 100 μg/mL), showing a transient decrease in the contractile effect in the small intestine segments treated with cumulative, increasing concentrations. …”

Pharmacological blockade of K_ATP channels negates the hippocampal synaptic and neuronal protection afforded by ketones. by Do Young Kim (131974)

“…Asterisks denote significant differences between experimental groups and the control at a specific time-point (*** <i>p</i> < 0.001). The dotted line indicates the mean PS amplitude of the control group. …”

<i>Sox2</i> and <i>Fgf20</i> interact during cochlea development—quantitative analysis. by Lu M. Yang (6919364)

“…Letters (L, I, J, O, P, S, T; representing each measurement in panels B-E) indicate a statistically significant decrease (p < 0.05) when comparing the row genotype against the column genotype. …”

Data_Sheet_1_Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19.PDF by Bizhen Chen (11567845)

“…</p><p>Results: Except for COVID-19, the total number of notifiable infectious diseases cases in 2020 was 6,366,176, a decrease of 41.38% year-on-year compared with 2019. …”

Fig 2 - by Valentina E. Yurinskaya (2735836)

“…<p>Calculated disturbance of ionic homeostasis in erythrocytes transferred to a hypotonic medium with a decrease in the concentration of NaCl (<b>A-D</b>) or to a hyperosmotic medium with the addition of NaCl or sucrose (<b>E-H</b>). …”

Direct Visualization of the Feedback Pulse by Leor S Weinberger (274196)

“…Performing the same exogenous Tat incubation with cells in which SirT1 is overexpressed from a retrovirus vector decreases the upward slope of the pulse (orange). …”

Influence of <i>k</i>₁ on the homeostatic behavior of the m7 ping-pong controller when <i>E</i>₁ binds first to free enzyme <i>Ez</i>. by Qaiser Waheed (5095328)

“…(c) A decrease of <i>k</i>₆ from 5.0 to 1.0 while <i>k</i>₁ is kept at 100.0 gives a general improvement of the homeostatic performance of the ping-pong controller, except for the higher end <i>k</i>₅ range between 900–1000, where <i>A</i>_<i>ss</i> becomes constant (indicated by the red circle). …”

Effect of the lytic enzyme PeiR on M1 growth <i>in vitro</i>. by Sinead C. Leahy (244590)

“…Chloroform, a known potent inhibitor of methanogens, resulted in a similarly reduced methane yield (B), but the decrease in culture density was less (A), as expected since it halts metabolism rather than lysing cells. …”

Dataset for: Leptin attenuates D2 receptor-mediated inhibition of putative ventral tegmental area dopaminergic neurons by Takami Murakami (4842903)

“…We suggest that leptin directly decreases, and indirectly increases, excitability of VTA dopaminergic neurons. …”

Hematoxylin and eosin staining with histomorphometric analysis of outflow vein removed from Iex-1^−/− and WT animals at day 28 after fistula placement. by Akshaar Brahmbhatt (551498)

“…Pooled data from the mean neointima area from <i>Iex-1</i> KO and WT animals are shown in <b>c.</b> There is a significant decrease in the mean area of the neointima in the <i>Iex-1</i> KO animals when compared to WT controls (P<0.05). …”

Table_1_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.DOCX... by Qi Zeng (221318)

“…</p>Results<p>From 1990 to 2019, the age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of interstitial lung disease and pulmonary sarcoidosis (ILD) slightly increased from 52.66 per 100,000 [95% uncertainty interval (UI) 44.49 to 61.07] to 57.62 per 100,000 (95% UI 49.42 to 65.67), from 1.76 per 100,000 (95% UI 1.41 to 2.22) to 2.17 per 100,000 (95% UI 1.5 to 2.62), and from 41.57 per 100,000 (95% UI 33.93 to 51.92) to 46.45 per 100,000 (95% UI 35.12 to 54.98), whereas the ASPR, ASMR, and ASDR of pneumoconiosis decreased. …”

Table_2_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.DOCX... by Qi Zeng (221318)

“…</p>Results<p>From 1990 to 2019, the age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of interstitial lung disease and pulmonary sarcoidosis (ILD) slightly increased from 52.66 per 100,000 [95% uncertainty interval (UI) 44.49 to 61.07] to 57.62 per 100,000 (95% UI 49.42 to 65.67), from 1.76 per 100,000 (95% UI 1.41 to 2.22) to 2.17 per 100,000 (95% UI 1.5 to 2.62), and from 41.57 per 100,000 (95% UI 33.93 to 51.92) to 46.45 per 100,000 (95% UI 35.12 to 54.98), whereas the ASPR, ASMR, and ASDR of pneumoconiosis decreased. …”

Image_1_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.JPEG... by Qi Zeng (221318)

“…</p>Results<p>From 1990 to 2019, the age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of interstitial lung disease and pulmonary sarcoidosis (ILD) slightly increased from 52.66 per 100,000 [95% uncertainty interval (UI) 44.49 to 61.07] to 57.62 per 100,000 (95% UI 49.42 to 65.67), from 1.76 per 100,000 (95% UI 1.41 to 2.22) to 2.17 per 100,000 (95% UI 1.5 to 2.62), and from 41.57 per 100,000 (95% UI 33.93 to 51.92) to 46.45 per 100,000 (95% UI 35.12 to 54.98), whereas the ASPR, ASMR, and ASDR of pneumoconiosis decreased. …”

Table_4_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.DOCX... by Qi Zeng (221318)

“…</p>Results<p>From 1990 to 2019, the age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of interstitial lung disease and pulmonary sarcoidosis (ILD) slightly increased from 52.66 per 100,000 [95% uncertainty interval (UI) 44.49 to 61.07] to 57.62 per 100,000 (95% UI 49.42 to 65.67), from 1.76 per 100,000 (95% UI 1.41 to 2.22) to 2.17 per 100,000 (95% UI 1.5 to 2.62), and from 41.57 per 100,000 (95% UI 33.93 to 51.92) to 46.45 per 100,000 (95% UI 35.12 to 54.98), whereas the ASPR, ASMR, and ASDR of pneumoconiosis decreased. …”

Table_3_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.DOCX... by Qi Zeng (221318)

“…</p>Results<p>From 1990 to 2019, the age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of interstitial lung disease and pulmonary sarcoidosis (ILD) slightly increased from 52.66 per 100,000 [95% uncertainty interval (UI) 44.49 to 61.07] to 57.62 per 100,000 (95% UI 49.42 to 65.67), from 1.76 per 100,000 (95% UI 1.41 to 2.22) to 2.17 per 100,000 (95% UI 1.5 to 2.62), and from 41.57 per 100,000 (95% UI 33.93 to 51.92) to 46.45 per 100,000 (95% UI 35.12 to 54.98), whereas the ASPR, ASMR, and ASDR of pneumoconiosis decreased. …”

Table_5_Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030.DOCX... by Qi Zeng (221318)

“…</p>Results<p>From 1990 to 2019, the age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of interstitial lung disease and pulmonary sarcoidosis (ILD) slightly increased from 52.66 per 100,000 [95% uncertainty interval (UI) 44.49 to 61.07] to 57.62 per 100,000 (95% UI 49.42 to 65.67), from 1.76 per 100,000 (95% UI 1.41 to 2.22) to 2.17 per 100,000 (95% UI 1.5 to 2.62), and from 41.57 per 100,000 (95% UI 33.93 to 51.92) to 46.45 per 100,000 (95% UI 35.12 to 54.98), whereas the ASPR, ASMR, and ASDR of pneumoconiosis decreased. …”